caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1518054931

Mona BijlaniMD

PsychiatryPiscataway, NJI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
1,200
Beneficiaries
—
Total drug cost
$83K
Distinct drugs
31
Brand share
10.8%
Top prescribed drugs
Clonazepam148 claims
Benztropine Mesylate94 claims
Olanzapine77 claims
Lorazepam73 claims
Risperidone68 claims
REFERRAL NETWORK

Where Mona Bijlani's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
JASSIN, BETH36270
ASHWORTH MSW, NANCY34332
VERDEROSA, KRISTYN3279
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
2259
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL, INC2168
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
86
Unique beneficiaries
—
Total services
265
Distinct HCPCS
2
Medicare payment
$16K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 667 Psychiatry providers in NJ — below median (cohort median 289).